Pharmacology and toxicology of xylazine: quid novum?

The current opioid overdose crisis is characterized by the presence of unknown psychoactive adulterants. Xylazine is an alpha-2 receptor agonist that is not approved for human use but is commonly used in veterinary medicine due to its sedative and muscle-relaxant properties. Cases of human intoxication due to accidental or voluntary use have been reported since the 1980s. However, reports of adulteration of illicit opioids (heroin and illicit fentanyl) with xylazine have been increasing all over Western countries. In humans, xylazine causes respiratory depression, bradycardia, and hypotension-posing individuals, using xylazine-adulterated opioids. We present a narrative review of the latest intoxication cases related to xylazine, to bring awareness to readers and also to help pathologists to detect and deal with xylazine cases

Analytic pulse technique for computational electromagnetics

Numerical modeling of electromagnetic waves is an important tool for understanding the interaction of light and matter, and lies at the core of computational electromagnetics. Traditional approaches to injecting and evolving electromagnetic waves, however, can be prohibitively expensive and complex for emerging problems of interest and can restrict the comparisons that can be made between simulation and theory. As an alternative, we demonstrate that electromagnetic waves can be incorporated analytically by decomposing the physics equations into analytic and computational parts. In particle-in-cell simulation of laser--plasma interaction, for example, treating the laser pulse analytically enables direct examination of the validity of approximate solutions to Maxwell's equations including Laguerre--Gaussian beams, allows lower-dimensional simulations to capture 3-D--like focusing, and facilitates the modeling of novel space--time structured laser pulses such as the flying focus. The flexibility and new routes to computational savings introduced by this analytic pulse technique are expected to enable new simulation directions and significantly reduce computational cost in existing areas.Comment: 26 pages, 9 figure

Coherence and superradiance from a plasma-based quasiparticle accelerator

Coherent light sources, such as free electron lasers, provide bright beams for biology, chemistry, physics, and advanced technological applications. Increasing the brightness of these sources requires progressively larger devices, with the largest being several km long (e.g., LCLS). Can we reverse this trend, and bring these sources to the many thousands of labs spanning universities, hospitals, and industry? Here we address this long-standing question by rethinking basic principles of radiation physics. At the core of our work is the introduction of quasi-particle-based light sources that rely on the collective and macroscopic motion of an ensemble of light-emitting charges to evolve and radiate in ways that would be unphysical when considering single charges. The underlying concept allows for temporal coherence and superradiance in fundamentally new configurations, providing radiation with clear experimental signatures and revolutionary properties. The underlying concept is illustrated with plasma accelerators but extends well beyond this case, such as to nonlinear optical configurations. The simplicity of the quasi-particle approach makes it suitable for experimental demonstrations at existing laser and accelerator facilities.Comment: 15 pages, 4 figure

Nonlinear Thomson scattering with ponderomotive control

In nonlinear Thomson scattering, a relativistic electron reflects and re-radiates the photons of a laser pulse, converting optical light to x rays or beyond. While this extreme frequency conversion offers a promising source for probing high-energy-density materials and driving uncharted regimes of nonlinear quantum electrodynamics, conventional nonlinear Thomson scattering has inherent tradeoffs in its scaling with laser intensity. Here we discover that the ponderomotive control afforded by spatiotemporal pulse shaping enables novel regimes of nonlinear Thomson scattering that substantially enhance the scaling of the radiated power, emission angle, and frequency with laser intensity. By appropriately setting the velocity of the intensity peak, a spatiotemporally shaped pulse can increase the power radiated by orders of magnitude. The enhanced scaling with laser intensity allows for operation at significantly lower electron energies and can eliminate the need for a high-energy electron accelerator

Exact solutions for the electromagnetic fields of a flying focus

The intensity peak of a "flying focus" travels at a programmable velocity over many Rayleigh ranges while maintaining a near-constant profile. Assessing the extent to which these features can enhance laser-based applications requires an accurate description of the electromagnetic fields. Here we present exact analytical solutions to Maxwell's equations for the electromagnetic fields of a constant-velocity flying focus, generalized for arbitrary polarization and orbital angular momentum. The approach combines the complex source-point method, which transforms multipole solutions into beam-like solutions, with the Lorentz invariance of Maxwell's equations. Propagating the fields backward in space reveals the space-time profile that an optical assembly must produce to realize these fields in the laboratory. Comparisons with simpler paraxial solutions provide conditions for their reliable use when modeling a flying focus

Human Hepatocyte 4-Acetoxy- N, N-Diisopropyltryptamine Metabolite Profiling by Reversed-Phase Liquid Chromatography Coupled with High-Resolution Tandem Mass Spectrometry

Tryptamine intoxications and fatalities are increasing, although these novel psychoactive substances (NPS) are not controlled in most countries. There are few data on the metabolic pathways and enzymes involved in tryptamine biotransformation. 4-acetoxy-N,N-diisopropyltryptamine (4-AcO-DiPT) is a synthetic tryptamine related to 4-hydroxy-N,N-diisopropyltryptamine (4-OH-DiPT), 4-acetyloxy-N,N-dipropyltryptamine (4-AcO-DPT), and 4-acetoxy-N,N-dimethyltryptamine (4-AcO-DMT). The aim of this study was to determine the best 4-AcO-DiPT metabolites to identify 4-AcO-DiPT consumption through human hepatocyte metabolism and high-resolution mass spectrometry. 4-AcO-DiPT metabolites were predicted in silico with GLORYx freeware to assist in metabolite identification. 4-AcO-DiPT was incubated with 10-donor-pooled human hepatocytes and sample analysis was performed with reversed-phase liquid chromatography coupled with high-resolution tandem mass spectrometry (LC-HRMS/MS) in positive- and negative-ion modes. Software-assisted LC-HRMS/MS raw data mining was performed. A total of 47 phase I and II metabolites were predicted, and six metabolites were identified after 3 h incubation following ester hydrolysis, O-glucuronidation, O-sulfation, N-oxidation, and N-dealkylation. All second-generation metabolites were derived from the only first-generation metabolite detected after ester hydrolysis (4-OH-DiPT). The metabolite with the second-most-intense signal was 4-OH-iPT-sulfate followed by 4-OH-DiPT-glucuronide, indicating that glucuronidation and sulfation are common in this tryptamine’s metabolic pathway. 4-OH-DiPT, 4-OH-iPT, and 4-OH-DiPT-N-oxide are suggested as optimal biomarkers to identify 4-AcO-DiPT consumption

Fourth Generation of Synthetic Cannabinoid Receptor Agonists: A Review on the Latest Insights

Abstract Background: Over the past few years, an emerging number of new psychoactive substances (NPSs) entered the illicit market. NPSs are designed to resemble the effects of classical drugs of abuse, reinforcing their effects and duration. Among the most abused NPS, synthetic cannabinoids are cannabinoid receptor agonists (SCRAs) that mimic the effect of the main psychotropic phytocannabinoid Δ9-tetrahydrocannabinol (THC). Methods: We herein reviewed the international literature to provide available information on the newest SCRAs generation. Results: Compared to the previous SCRAs generations, the structures of the last generation result in increased affinity for and efficacy at cannabinoid CB1 receptors, which are thought to be mainly responsible for the psy-choactive effects of THC and its analogues. Accordingly, these more potent cannabimimetic effects may increase the number of adverse reactions such as neurological disorders (e.g., psychosis, agitation, irritability, paranoia, confusion, and anxiety), psychiatric episodes (e.g., hallucinations, delusions, self-harm), other physical conditions (e.g., tachycardia, hypertension, arrhythmia, chest pain, nausea, vomiting, and fever) and deaths. In the last decade, more than a hundred SCRAs from different chemical classes emerged on the illicit web mar-ket. SCRAs have been thoroughly studied: they were physico-chemically characterized, and pharmaco-toxico-logical characteristics were investigated. The last SCRAs generations include increasingly potent and toxic com-pounds, posing a potential health threat to consumers. Conclusion: From November 2017 to February 2021, at least 20 new “fourth-generation” SCRAs were formal-ly reported to international drug agencies. Our understanding of the neurotoxicity of these compounds is still limited due to the lack of global data, but their potency and their toxicity are likely higher than those of the previous generations. © 2022 Bentham Science Publishers

Fourth Generation of Synthetic Cannabinoid Receptor Agonists: A Review on the Latest Insights

Background: Over the past few years, an emerging number of new psychoactive substances (NPSs) entered the illicit market. NPSs are designed to resemble the effects of classical drugs of abuse, reinforcing their effects and duration. Among the most abused NPS, synthetic cannabinoids are cannabinoid receptor agonists (SCRAs) that mimic the effect of the main psychotropic phytocannabinoid Delta(9)-tetrahydrocannabinol (THC). Methods: We herein reviewed the international literature to provide available information on the newest SCRAs generation. Results: Compared to the previous SCRAs generations, the structures of the last generation result in increased affinity for and efficacy at cannabinoid CB1 receptors, which are thought to be mainly responsible for the psychoactive effects of THC and its analogues. Accordingly, these more potent cannabimimetic effects may increase the number of adverse reactions such as neurological disorders (e.g., psychosis, agitation, irritability, paranoia, confusion, and anxiety), psychiatric episodes (e.g., hallucinations, delusions, self-harm), other physical conditions (e.g., tachycardia, hypertension, arrhythmia, chest pain, nausea, vomiting, and fever) and deaths. In the last decade, more than a hundred SCRAs from different chemical classes emerged on the illicit web market. SCRAs have been thoroughly studied: they were physico-chemically characterized, and pharmaco-toxicological characteristics were investigated. The last SCRAs generations include increasingly potent and toxic compounds, posing a potential health threat to consumers. Conclusion: From November 2017 to February 2021, at least 20 new "fourth-generation" SCRAs were formally reported to international drug agencies. Our understanding of the neurotoxicity of these compounds is still limited due to the lack of global data, but their potency and their toxicity are likely higher than those of the previous generations

Pharmacology and toxicology of xylazine: quid novum?

: The current opioid overdose crisis is characterized by the presence of unknown psychoactive adulterants. Xylazine is an alpha-2 receptor agonist that is not approved for human use but is commonly used in veterinary medicine due to its sedative and muscle-relaxant properties. Cases of human intoxication due to accidental or voluntary use have been reported since the 1980s. However, reports of adulteration of illicit opioids (heroin and illicit fentanyl) with xylazine have been increasing all over Western countries. In humans, xylazine causes respiratory depression, bradycardia, and hypotension-posing individuals, using xylazine-adulterated opioids. We present a narrative review of the latest intoxication cases related to xylazine, to bring awareness to readers and also to help pathologists to detect and deal with xylazine cases